AU2001298029A1 - Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydro isoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases - Google Patents
Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydro isoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseasesInfo
- Publication number
- AU2001298029A1 AU2001298029A1 AU2001298029A AU2001298029A AU2001298029A1 AU 2001298029 A1 AU2001298029 A1 AU 2001298029A1 AU 2001298029 A AU2001298029 A AU 2001298029A AU 2001298029 A AU2001298029 A AU 2001298029A AU 2001298029 A1 AU2001298029 A1 AU 2001298029A1
- Authority
- AU
- Australia
- Prior art keywords
- phenylamino
- derivatives
- treatment
- receptor antagonists
- neurodegenerative diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01500003.7 | 2001-01-05 | ||
| EP01500003 | 2001-01-05 | ||
| PCT/US2001/045858 WO2003024934A2 (fr) | 2001-01-05 | 2001-12-19 | Antagonistes des recepteurs d'aminoacides excitatoires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001298029A1 true AU2001298029A1 (en) | 2003-04-01 |
Family
ID=8183455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001298029A Abandoned AU2001298029A1 (en) | 2001-01-05 | 2001-12-19 | Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydro isoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1351689A2 (fr) |
| AU (1) | AU2001298029A1 (fr) |
| WO (1) | WO2003024934A2 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2398225T3 (es) | 2002-04-26 | 2013-03-14 | Eli Lilly And Company | Derivados de éster de un ácido DECAHIDROISOQUINOLIN-3-CARBOXÍLICO como analgésicos |
| CA2623759A1 (fr) * | 2005-10-06 | 2007-04-19 | Exelixis, Inc. | Inhibiteurs de pim-1 et/ou de pim-3 a base de pyridopyrimidinone |
-
2001
- 2001-12-19 EP EP01274482A patent/EP1351689A2/fr not_active Withdrawn
- 2001-12-19 WO PCT/US2001/045858 patent/WO2003024934A2/fr not_active Application Discontinuation
- 2001-12-19 AU AU2001298029A patent/AU2001298029A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003024934A3 (fr) | 2003-07-24 |
| WO2003024934A2 (fr) | 2003-03-27 |
| EP1351689A2 (fr) | 2003-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002252373A1 (en) | Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders | |
| WO2003033720A8 (fr) | Proteine a base de variants de tnf-alpha pour le traitement de troubles associes au tnf-alpha | |
| AU1474001A (en) | Compositions and methods for treatment of neurological disorders and neurodegenerative diseases | |
| AU2002327378A1 (en) | Treatment of neuropsychiatric disorders by near-diaphragmatic nerve stimulation | |
| EP1511730B8 (fr) | Derives de diaryle-uree utilises pour le traitement des maladies dependant des proteines kinases | |
| IL169091A0 (en) | Benzazepine derivatives for the treatment of neurological disorders | |
| AU2003291992A1 (en) | Phenylethanolamine derivatives for the treatment of respiratory diseases | |
| AU2003285091A1 (en) | Interferon antagonists useful for the treatment of interferon related diseases | |
| AU2002356525A1 (en) | Substituted amines for the treatment of neurological disorders | |
| EP1897550A3 (fr) | Promédicaments d'acides amines excitateurs | |
| AU2002334870B8 (en) | Combinations for the treatment of immunoinflammatory disorders | |
| WO2001098279A3 (fr) | Bis-arylsulfones | |
| AU6205700A (en) | Azo amino acid derivatives for the treatment of neurological diseases | |
| AU2002240359A1 (en) | Pharmaceutical composition for the treatment of alopecia | |
| HUP0303751A3 (en) | Use of n-phenyl-2-pyrimidineamine derivatives for preparation of pharmaceutical compositions suitable for treating mast cell-based diseases like allergic disorders | |
| HK1080859A1 (en) | Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders | |
| AU2002362115A1 (en) | Composition and methods for treatment of neurological disorders | |
| AU2002227895A1 (en) | Sulphonamides for the treatment of central nervous system diseases | |
| AU5912900A (en) | Quinuclidine derivatives for treatment of neurological disorders | |
| HK1057332A1 (en) | Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders | |
| AU2001298029A1 (en) | Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydro isoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases | |
| IL160852A0 (en) | Pharmaceutical compositions for the treatment of urinary disorders | |
| AU6076000A (en) | Cyclic amine derivatives for the treatment of neurological diseases | |
| WO2002080911A3 (fr) | Utilisation de composes imidazo[1,2-a]-pyridine-3-yl-amide- et imidazo[1,2-a]-pyridine-3-yl-amine substitues comme medicaments | |
| AU2003273856A1 (en) | Vr1 antagonists for the treatment of urological disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |